XTXiaomei Bs Tang

Xiaomei Bs Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaomei Bs Tang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic evidence for causal associations between common cell-derived signaling molecules and sleep disorders and the mediating role of metabolites

    by Liqun Li, Xiaomei Tang, Jinjing Tan, Jing Yan, Chunmei Wang, Jiaqi Li, Zhiwen Shen, Sheng Xie

    Although the potential causal associations between cell-derived signaling molecules and sleep disorder (SD) have been reported, contradictions remain. This study assessed the causal effects and the mediating role of 1400 metabolites among 91 cell-derived signaling molecules and SD from a genetic perspective by performing Mendelian randomization (MR) analyses. Genetic instruments derived from publicly available genome-wide association studies were employed in this study, including 49,880 SD cases and 358,194 controls. Summary statistics of 1400 circulating metabolites were obtained from a cohort of 8299 individuals. The 91 cell-derived signaling molecules were derived from genome-wide association studies data from 11 cohorts comprising 14,824 samples. Multiple statistical analyses were introduced in this study, with inverse variance weighted as the core analysis method, supplemented by 4 additional methods. Besides, various sensitivity analyses were employed to identify horizontal pleiotropy and heterogeneity, thereby evaluating the robustness of the results. Forward MR analysis indicated positive associations between SD and the levels of eotaxin (OR = 1.041, 95% CI: 1.001–1.084, P = .046), CUB domain-containing protein 1 (OR = 1.042, 95% CI: 1.008–1.077, P = .016), interleukin-20 receptor subunit alpha (IL-20RA) (OR = 1.086, 95% CI: 1.031–1.143, P = .002), while the levels of CD40L receptor (OR = 0.968, 95% CI: 0.942–0.994, P = .018), glial cell line-derived neurotrophic factor (OR = 0.947, 95% CI: 0.910–0.986, P = .009) act as the opposite. Reverse MR analysis pointed out that the genetic susceptibility to SD raised interleukin-5 levels. According to the mediation analysis, N-lactoyl-tyrosine levels mediated the increased risks of SD associated with elevated IL-20RA levels, with a mediation effect of 0.009 (95% CI: 0.001–0.018, P = .034), accounting for 11.5% of the total. The study proved the causal associations between 91 cell-derived signaling molecules and SD, confirming that eotaxin, CUB domain-containing protein 1, and IL-20RA may increase the risk of SD, while CD40L receptor and glial cell line-derived neurotrophic factor may act as the opposite. Besides, the study provided abundant evidence for the potential mediating effect of N-lactoyl-tyrosine in the pathway linking IL-20RA and SD risk. To summarize, the findings of this study may benefit the understanding of the pathogenic mechanisms through which cell-derived signaling molecules influence SD.

  • Open Access

    Association of MCP-4, NRTN, and PD-L1 with the risk of hepatic fibrosis: A Mendelian randomization study

    by Liqun Mm Li, Jing Mm Yan, Qian Bs Liu, Laian Ge, Yifeng Mm Pan, Bingjie Bs Han, Chunmei Bs Wang, Xiaomei Bs Tang, Lijian Mm Liu, Sheng Mm Xie

    Previous studies have confirmed the affiliation between specific inflammatory cytokines and Hepatic fibrosis (HF); however, contradictions remain in the causality. The study implemented a bidirectional two-sample Mendelian randomization (MR) analysis with published statistics derived from Genome-wide Association Studies (GWAS) to investigate casualties between inflammatory cytokines and HF. Additionally, MR analysis was also introduced to consider if 1400 blood metabolites act as the key mediators in this process. Single nucleotide polymorphisms (SNPs) with strong correlations to inflammatory factors were selected for multiple MR analyses in this study. The inverse variance weighted method (IVW) was chosen as the principal analysis, and the others as the supportive. Besides, sensitivity tests were involved to identify potential heterogeneity and pleiotropic level. IVW methods revealed that a relatively high level of prediction-based monocyte chemoattractant protein-4 (MCP-4) (95% CI: 1.014–3.336, P = .045), along with neurturin (NRTN) (95% CI: 1.204–4.004, P = .010), may increase the risk of HF; while programmed cell death 1 ligand 1 (PD-L1) (95% CI: 0.223–0.928, P = .030), showed a protective effect on HF. No significant statistical differences were detected on any other inflammatory cytokines, nor did the impact of HF genetic predisposition on the 91 circulating inflammatory cytokines-related characteristics.